Esparma GmbH
🏢 View company profile →5Patents
0Active
5Granted
23Portfolio score
Filing activity: Sep 5, 2001 → May 27, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6719986B1 | Hyaluronate lyase used for promoting penetration in topical agents | Human Necessities | 12 | Expired |
| US6689349B1 | Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis | Human Necessities | 3 | Expired |
| US6518300B2 | Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (&agr;-lipoic acid) or its physiologically compatible salts | Human Necessities | 1 | Expired |
| US6413950B1 | Pharmaceutical preparation containing dithranol | Human Necessities | 0 | Expired |
| US7429614B2 | Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.